# Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.

Study · id `cardio:ct-nct01918215` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01918215](<https://clinicaltrials.gov/study/NCT01918215>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01918215

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 453 participants.

## Technical summary

Registry record NCT01918215. Randomized; no masking; primary purpose prevention. Start 2015-07 (actual); primary completion 2026-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 453 participants (enrolled count; ClinicalTrials.gov record NCT01918215, source copy `cardio:ctgov-nct01918215-2026-07-08`, retrieved 2026-11-18)
- Started: 2015-07 (actual) (ClinicalTrials.gov record NCT01918215, source copy `cardio:ctgov-nct01918215-2026-07-08`, retrieved 2026-11-18)
- Primary completion: 2026-04 (actual) (ClinicalTrials.gov record NCT01918215, source copy `cardio:ctgov-nct01918215-2026-07-08`, retrieved 2026-11-18)
- Completion: 2026-05-12 (actual) (ClinicalTrials.gov record NCT01918215, source copy `cardio:ctgov-nct01918215-2026-07-08`, retrieved 2026-11-18)
- Countries: Australia; Germany; United Kingdom (ClinicalTrials.gov record NCT01918215, source copy `cardio:ctgov-nct01918215-2026-07-08`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01918215-2026-07-08`, retrieved 2026-11-18)

## The registry's words

- Brief title: Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.
- Acronym: CMR\_GUIDE
- Condition: Heart Failure
- Condition: Left Ventricular Systolic Dysfunction
- Intervention (Device): ICD
- Intervention (Device): ILR
- Lead sponsor: Flinders University
- Lead sponsor class: OTHER
- Collaborator: South Australian Health and Medical Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: a59cfe48678ac002947fcd9eb5f591f5d498f32a92d0a842cb05b2a4074871a4
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
